AAN 2017 – Dan Hanley Interview
Prof. Dan Hanley summarizes the current treatment landscape and unmet needs in intraventricular hemorrhage, and discusses the findings of the CLEAR III trial. He also gives his insight into the commonly used methods to measure quality of life in survivors of hemorrhagic stroke.
Speaker disclosures: Dr Hanley has grants to study ICH and IVH removal, which are funded by the National Institute of Neurological Disorders and Stroke (CLEAR and MISTIE) as well as a sponsored research agreement with Genentech, the manufacturer of rt-PA. He also receives a grant as part of the National Center for Advancing Translational Sciences’ Clinical and Translational Science Award Program.
Filmed at the American Academy of Neurology (AAN) Annual Meeting, Boston, US, April 2017
Share this Video
Related Videos In Stroke
Update on the European Stroke Organisation Conference (ESOC) 2023: Peter Kelly
The European Stroke Organisation Conference (ESOC) 2023 will take place 24-26 May 2023 in Munich, Germany. The conference will include sessions, plenary lectures, and symposia, covering a wide range of topics related to stroke, including acute management, rehabilitation, imaging, epidemiology, and public health. Prof. Peter Kelly (President, European Stroke Organisation, Dublin, Ireland) joins touchNEUROLOGY to […]
Hariklia Proios, Stroke Alliance for Europe (SAFE): Presidential Update
The Stroke Alliance for Europe (SAFE) is a non-profit-making organisation that represents a range of patient groups from across Europe. Their mutual goal is to drive stroke prevention up the European political agenda and prevent the incidence of stroke through education. touchNEUROLOGY caught up with the SAFE President, Prof. Hariklia (Harriet) Proios, to discuss the […]
Martin Bretzner, ESOC 2022: Brain-age biomarkers to predict post-stroke recovery
Brain-age biomarkers can be used to predict post-stroke recovery. Dr Martin Bretzner (Lille Neuroscience & Cognition Research Centre, Lille University Hospital, Lille, France) discusses the results of a study using radiomics, an emerging image-quantifying technology to assess ‘brain-age’ biomarkers. The study investigates how relative brain age, rather than chronological age, can enhance stroke surveillance and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!